Clinical Trials

ORCATECH's data collection and analysis model for detecting change in clinical trials is illustrated below.

ORCATECH Clinical Trials Schematic/Flow chart graphic

Specific Health Outcomes

A unique characteristic of ORCATECH's system is the ability to design and implement studies looking at specific health outcomes, such as:

  • Medication Adherence
  • Mobility
  • Cognition
  • Sleep
  • Pain
  • Socialization
  • Behavioral Health

These health outcomes have been investigated across a variety of conditions, including:

  • Alzheimer's Disease
  • Parkinson's Disease
  • Chronic Pain Disorders
  • Multiple Sclerosis

The ORCATECH Advantage

The ORCATECH platforms are powerful, customizable tools designed to provide crucial information relating to participants’ health metrics over time to clinicians and developers of medical products (both device and pharmaceutical).

The platforms consist of a set of technology and algorithms that improve data quality while reducing time and cost. The breadth, fidelity, and granularity or resolution of the captured data cannot be obtained through conventional patient-health-providers’ interactions during typical brief episodic visits to the doctor or emergency department. Further, the quality of the information collected during such occasions, is not only limited by the length of the interaction, but by the patient’s memory or perception of events, during an interaction that transpires in an often emotionally uncomfortable setting.

The remotely installed systems are complemented and supported by a field team of clinicians and technical assistants who professionally manage participants’ recruitment and in addition perform all the required-in home personal interactions and medical exams. Clinical experts, each in their respective field, are engaged in the entire process and synthesize clinical conclusions and actionable outcomes from the multi-dimensional information created.


Initiating a Clinical Trial with ORCATECH

Please contact Chief Business and Operations Director to inquire about setting up a clinical trial.